Response to Boland et al. “Appraisal of the references supporting STOPP/START version 3 criteria”
Authors:
- 10 June 2026
- journal article
- Published by Springer Nature in European Geriatric Medicine
- Vol. 17 (3) , 1201-1204
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Appraisal of the references supporting the STOPP/START.version 3 criteriaEuropean Geriatric Medicine, 2025
- STOPP/START criteria for potentially inappropriate prescribing in older people: version 3European Geriatric Medicine, 2023
- Use of Delphi in health sciences research: A narrative reviewMedicine, 2023
- Real‐World Evidence in EU Medicines Regulation: Enabling Use and Establishing ValueClinical Pharmacology & Therapeutics, 2021
- Renal safety in patients treated with bisphosphonates for osteoporosis: A reviewJournal of Bone and Mineral Research, 2013
- Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double‐blind, placebo‐controlled, phase III studiesInternational Journal Of Clinical Practice, 2013
- Fighting Against Age Discrimination in Clinical TrialsJournal of the American Geriatrics Society, 2010
- Aspirin to Prevent Heart Attack and Stroke: What’s the Right Dose?The American Journal of Medicine, 2006
- Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinenceBJOG: An International Journal of Obstetrics & Gynaecology, 2004
- Duloxetine versus placebo in the treatment of stress urinary incontinenceAmerican Journal of Obstetrics and Gynecology, 2002